| Q35088087 | "Routine invasive" versus "selective invasive" approaches to non-ST-segment elevation acute coronary syndromes management in the post-stent/platelet inhibition era. |
| Q35546171 | A Novel Risk Stratification Model for Patients with Non-ST Elevation Myocardial Infarction in the Korea Acute Myocardial Infarction Registry (KAMIR): Limitation of the TIMI Risk Scoring System |
| Q36329165 | A cross-sectional multicentre study of cardiac risk score use in the management of unstable angina and non-ST-elevation myocardial infarction |
| Q35096829 | A genetic fuzzy system for unstable angina risk assessment |
| Q36578446 | A modified HEART risk score in chest pain patients with suspected non-ST-segment elevation acute coronary syndrome |
| Q36766317 | A new simplified immediate prognostic risk score for patients with acute myocardial infarction |
| Q36994705 | A novel cardiovascular risk stratification model incorporating ECG and heart rate variability for patients presenting to the emergency department with chest pain |
| Q28167379 | A population-based evaluation of the thrombolysis in myocardial infarction risk score for unstable angina and non-ST elevation myocardial infarction |
| Q82917984 | A prior myocardial infarction: how does it affect management and outcomes in recurrent acute coronary syndromes? |
| Q47998925 | A retrospective external validation study of the HEART score among patients presenting to the emergency department with chest pain |
| Q28188404 | A risk score system for predicting adverse outcomes and magnitude of benefit with glycoprotein IIb/IIIa inhibitor therapy in patients with unstable angina pectoris |
| Q33318584 | A study to derive a clinical decision rule for triage of emergency department patients with chest pain: design and methodology |
| Q33820857 | A variant at chromosome 9p21 is associated with recurrent myocardial infarction and cardiac death after acute coronary syndrome: the GRACE Genetics Study |
| Q34154695 | ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice g |
| Q37140988 | ACHTUNG-Rule: a new and improved model for prognostic assessment in myocardial infarction. |
| Q47111055 | ACTION (acute coronary treatment and intervention outcomes network) registry-GWTG (get with the guidelines) risk score predicts long-term mortality in acute myocardial infarction |
| Q41083032 | ANMCO-SIMEU Consensus Document: in-hospital management of patients presenting with chest pain |
| Q73245550 | Acute Myocardial Infarction: Antithrombotic Therapy |
| Q84183388 | Acute coronary syndrome in patients with a coronary artery bypass graft |
| Q36849726 | Acute coronary syndromes without ST segment elevation |
| Q30490718 | Acute coronary syndromes: diagnosis and management, part I |
| Q54069247 | Acute myocardial infarction |
| Q87984710 | An external validation of the HEART pathway among Emergency Department patients with chest pain |
| Q42694751 | An invasive strategy is associated with decreased mortality in patients with unstable angina and non-ST-elevation myocardial infarction: GUSTO IIb trial |
| Q28218702 | Antiplatelet therapy in populations at high risk of atherothrombosis |
| Q37678955 | Antithrombotic therapy in acute coronary syndromes: guidelines translated for the clinician |
| Q91605535 | Application of Risks Scores in Acute Coronary Syndromes. How Does ProACS Hold Up Against Other Risks Scores? |
| Q41674416 | Appropriateness of diagnosis of unstable angina pectoris in patients referred for coronary arteriography |
| Q37206349 | Aspiration Thrombectomy and Drug-Eluting Stent Implantation Decrease the Occurrence of Angina Pectoris One Year After Acute Myocardial Infarction |
| Q28195666 | Aspirin inhibits surface glycoprotein IIb/IIIa, P-selectin, CD63, and CD107a receptor expression on human platelets |
| Q47191213 | Association between mean systolic and diastolic blood pressure throughout the follow-up and cardiovascular events in acute myocardial infarction patients with systolic dysfunction and/or heart failure: an analysis from the High-Risk Myocardial Infar |
| Q43435430 | Association of the PURSUIT risk score with predischarge ejection fraction, angiographic severity of coronary artery disease, and mortality in a nonselected, community-based population with non-ST-elevation acute myocardial infarction. |
| Q43651434 | Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: results from the PURSUIT trial |
| Q34035094 | B-type natriuretic peptide and high sensitive C-reactive protein predict 2-year all cause mortality in chest pain patients: a prospective observational study from Salta, Argentina |
| Q33387034 | B-type natriuretic peptide is a long-term predictor of all-cause mortality, whereas high-sensitive C-reactive protein predicts recurrent short-term troponin T positive cardiac events in chest pain patients: a prognostic study |
| Q37156100 | Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score |
| Q33596823 | Biomarkers in acute myocardial infarction. |
| Q52567727 | CHA2 DS2 -VASc score and clinical outcomes of patients with chest pain discharged from internal medicine wards following acute coronary syndrome rule-out. |
| Q34369733 | Cardiac markers and risk stratification: an integrated approach |
| Q36769820 | Caveolin and caveolae in age associated cardiovascular disease |
| Q47718667 | Caveolins as regulators of stress adaptation |
| Q35286413 | Caveolins in cardioprotection - translatability and mechanisms |
| Q58464349 | Challenges and opportunities in quantifying the quality of care for acute myocardial infarction |
| Q34071675 | Changes in clinical profile, treatment, and mortality in patients hospitalised for acute myocardial infarction between 1985 and 2008 |
| Q34430115 | Chemokines CCL3/MIP1α, CCL5/RANTES and CCL18/PARC are independent risk predictors of short-term mortality in patients with acute coronary syndromes |
| Q36742346 | Chest pain in the emergency room: value of the HEART score |
| Q33795578 | Clinical characteristics and short-term outcomes in patients with elevated admission systolic blood pressure after acute ST-elevation myocardial infarction: a population-based study |
| Q35331929 | Clinical decision-making of cardiologists regarding admission and treatment of patients with suspected unstable angina or non-ST-elevation myocardial infarction: protocol of a clinical vignette study |
| Q30627641 | Clinical, electrocardiographic, and biochemical data for immediate risk stratification in acute coronary syndromes |
| Q37576804 | Cohort profile of BIOMArCS: the BIOMarker study to identify the Acute risk of a Coronary Syndrome-a prospective multicentre biomarker study conducted in the Netherlands |
| Q89119253 | Comparison of clinical risk scores for triaging high-risk chest pain patients at the emergency department |
| Q60302475 | Comparison of nine coronary risk scores in evaluating patients presenting to hospital with undifferentiated chest pain |
| Q37680572 | Comparison of the GRACE risk score and the TIMI risk index in predicting the extent and severity of coronary artery disease in patients with acute coronary syndrome |
| Q42716722 | Composite risk scores for acute coronary syndromes |
| Q93216752 | Construction and analysis for differentially expressed long non-coding RNAs and mRNAs in acute myocardial infarction |
| Q43479440 | Contemporary outcome of cardiac catheterizations in 1085 consecutive octogenarians |
| Q33776221 | Contemporary treatment of unstable angina and non-ST-segment-elevation myocardial infarction (part 1). |
| Q35037630 | Critical review of unstable angina and non-ST elevation myocardial infarction |
| Q36527845 | Current status of risk stratification methods in acute coronary syndromes |
| Q33920774 | Derivation and validation of a risk standardization model for benchmarking hospital performance for health-related quality of life outcomes after acute myocardial infarction |
| Q37225901 | Diagnostic accuracy of clinical prediction rules to exclude acute coronary syndrome in the emergency department setting: a systematic review. |
| Q64241716 | Discharge Heart Rate After Hospitalization for Myocardial Infarction and Long-Term Mortality in 2 US Registries |
| Q36000480 | Discrepancies between the medical record and the reports of patients with acute coronary syndrome regarding important aspects of the medical history |
| Q35017934 | Discrepancy between clinician and research assistant in TIMI score calculation (TRIAGED CPU) |
| Q59208809 | Does Continuous ST-Segment Monitoring Add Prognostic Information to the TIMI, PURSUIT, and GRACE Risk Scores? |
| Q44773687 | Does initial and delayed heart rate predict mortality in patients with acute coronary syndromes? |
| Q47131132 | Double product reflects the association of heart rate with MACEs in acute coronary syndrome patients treated with percutaneous coronary intervention. |
| Q38137724 | Dual antiplatelet therapy dilemmas: duration and choice of antiplatelets in acute coronary syndromes |
| Q44041809 | Early angioplasty in acute coronary syndromes without persistent ST-segment elevation improves outcome but increases the need for six-month repeat revascularization: an analysis of the PURSUIT Trial. Platelet glycoprotein IIB/IIIA in Unstable angina |
| Q51873417 | Early intervention: which patients and how early? |
| Q34674187 | Early invasive strategies for acute coronary syndromes |
| Q73090421 | Early non-invasive management of acute coronary syndromes |
| Q44420954 | Early use of glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute myocardial infarction: observations from the National Registry of Myocardial Infarction 4. |
| Q51739254 | Echocardiographic parameters as predictors of in-hospital mortality in patients with acute coronary syndrome undergoing percutaneous coronary intervention. |
| Q33769751 | Effect of initial temperature changes on myocardial enzyme levels and cardiac function in acute myocardial infarction |
| Q45902457 | Effect of invasive treatment on prognosis in non-ST-segment elevation acute coronary syndrome with or without systolic dysfunction. |
| Q43571946 | Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study |
| Q44621238 | Effect of platelet glycoprotein IIb/IIIa receptor blockade with tirofiban on adverse cardiac events in women with unstable angina/non-ST–elevation myocardial infarction (PRISM-PLUS study) |
| Q44512679 | Effect of revascularization on mortality associated with an elevated white blood cell count in acute coronary syndromes |
| Q42873344 | Effects of Aging on Isoflurane-Induced and Protein Kinase A-Mediated Activation of ATP-Sensitive Potassium Channels in Cultured Rat Aortic Vascular Smooth Muscle Cells |
| Q37103506 | Efficacy and safety outcomes of ticagrelor compared with clopidogrel in elderly Chinese patients with acute coronary syndrome |
| Q33744203 | Emergency department and office-based evaluation of patients with chest pain |
| Q28198893 | Eptifibatide: a pharmacoeconomic review of its use in percutaneous coronary intervention and acute coronary syndromes |
| Q28166580 | Evaluating the benefits of glycoprotein IIb/IIIa inhibitors in heart failure at baseline in acute coronary syndromes |
| Q64062397 | Evidential MACE prediction of acute coronary syndrome using electronic health records |
| Q37453028 | Explicit risk in acute coronary syndrome management |
| Q35584557 | FRISC score for selection of patients for an early invasive treatment strategy in unstable coronary artery disease |
| Q34994616 | Fluorescent advanced glycation end products and their soluble receptor: the birth of new plasmatic biomarkers for risk stratification of acute coronary syndrome. |
| Q35129963 | GRACE and TIMI risk scores but not stress imaging predict long-term cardiovascular follow-up in patients with chest pain after a rule-out protocol |
| Q58863669 | High level of physical activity preserves the cardioprotective effect of preinfarction angina in elderly patients |
| Q34994933 | Hypercholesterolemia paradox in relation to mortality in acute coronary syndrome. |
| Q33266834 | ICD-10 coding algorithms for defining comorbidities of acute myocardial infarction |
| Q30991599 | Identification of patients with evolving coronary syndromes by using statistical models with data from the time of presentation. |
| Q37038768 | Impact of 6-mo caloric restriction on myocardial ischemic tolerance: possible involvement of nitric oxide-dependent increase in nuclear Sirt1. |
| Q30665284 | Impact of family history on the presentation and clinical outcomes of coronary heart disease: data from the Korea Acute Myocardial Infarction Registry. |
| Q47099826 | Impact of heart rate in atrial fibrillation versus sinus rhythm on mortality in octogenarian patients with acute coronary syndrome |
| Q33586456 | Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST). |
| Q33663481 | Improving the management of non-ST elevation acute coronary syndromes: systematic evaluation of a quality improvement programme European QUality Improvement Programme for Acute Coronary Syndrome: the EQUIP-ACS project protocol and design |
| Q33614396 | In-hospital complications after invasive strategy for the management of Non STEMI: women fare as well as men. |
| Q37090714 | Individualized Angiotensin-Converting Enzyme (ACE)-Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model |
| Q34748390 | Influence of comorbid conditions on one-year outcomes in non-ST-segment elevation acute coronary syndrome |
| Q40690968 | Integration of Different Risk Assessment Tools to Improve Stratification of Patients with Coronary Artery Disease |
| Q44314858 | Interactions between age, outcome of acute coronary syndromes, and tirofiban therapy |
| Q41764802 | Ischemic preconditioning in the younger and aged heart. |
| Q36031243 | Korean National Health Insurance value incentive program: achievements and future directions |
| Q35581944 | Learning on the Web. Case 3: acute chest pain |
| Q22252556 | Left ventricular ejection fraction to predict early mortality in patients with non–ST-segment elevation acute coronary syndromes |
| Q93139355 | Lipid transfer to high-density lipoproteins in coronary artery disease patients with and without previous cerebrovascular ischemic events |
| Q36928252 | Long term prognosis of heart failure after acute coronary syndromes without ST elevation |
| Q36706382 | Long-term outcomes in high-risk patients with non-ST-segment elevation myocardial infarction |
| Q34053362 | Management of patients with non-ST-segment elevation acute coronary syndromes: insights from the PURSUIT trial. |
| Q24653318 | Management of patients with unstable angina / non-ST-elevation myocardial infarction: a critical review of the 2007 ACC /AHA guidelines |
| Q54356235 | Microvascular obstruction in patients with non-ST-elevation myocardial infarction: a contrast-enhanced cardiac magnetic resonance study. |
| Q37496035 | Mid-term Risk Stratification of Patients with a Myocardial Infarction and Atrial Fibrillation: Beyond GRACE and CHADS |
| Q35581714 | Modern risk stratification in coronary heart disease. |
| Q33906082 | Monitoring guideline adherence in the management of acute coronary syndrome in hospitals: design of a multicentre study |
| Q53141587 | Mortality trends for non-ST-segment elevation myocardial infarction (NSTEMI) in the United States from 1988 to 2004. |
| Q35806730 | Myocardial infarction in the elderly |
| Q48532255 | N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation |
| Q39431752 | New advances in the management of acute coronary syndromes |
| Q33955730 | New advances in the management of acute coronary syndromes: 1. Matching treatment to risk. |
| Q79248825 | New insight into clinical risk scores for patients with acute coronary syndromes |
| Q36519924 | Non ST segment elevation acute coronary syndromes: A simplified risk-orientated algorithm |
| Q36185831 | Non-ST-segment elevation acute coronary syndromes: targeted imaging to refine upstream risk stratification |
| Q35575676 | Optimizing glycoprotein IIb/IIIa receptor antagonist use for the non-ST–segment elevation acute coronary syndromes: risk stratification and therapeutic intervention |
| Q37599585 | Outcomes among non-ST-segment elevation acute coronary syndromes patients with no angiographically obstructive coronary artery disease: observations from 37,101 patients |
| Q37119085 | Paradoxical use of invasive cardiac procedures for patients with non-ST segment elevation myocardial infarction: an international perspective from the CRUSADE Initiative and the Canadian ACS Registries I and II. |
| Q37142428 | Patients with cardiac disease: Changes observed through last decade in out-patient clinics |
| Q28193946 | Pharmacological treatment of elderly patients with acute coronary syndromes without persistent ST segment elevation |
| Q37599613 | Plasma osmolality predicts clinical outcome in patients with acute coronary syndrome undergoing percutaneous coronary intervention. |
| Q90432497 | Platelet function, coagulation and fibrinolysis in patients with previous coronary and cerebrovascular ischemic events |
| Q56944618 | Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials |
| Q36019811 | Platelet glycoprotein IIb/IIIa receptor antagonists in non-ST segment elevation acute coronary syndromes: a review and guide to patient selection |
| Q44472981 | Poverty, process of care, and outcome in acute coronary syndromes |
| Q37076076 | Predicting Outcomes Over Time in Patients With Heart Failure, Left Ventricular Systolic Dysfunction, or Both Following Acute Myocardial Infarction |
| Q36608168 | Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial |
| Q22242088 | Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) |
| Q37697203 | Prediction of the risk of mortality using risk score in patients with coronary heart disease |
| Q36645766 | Predictive models for short- and long-term adverse outcomes following discharge in a contemporary population with acute coronary syndromes |
| Q93167973 | Predictors of all-cause mortality and ischemic events within and beyond 1 year after an acute coronary syndrome: Results from the EPICOR registry |
| Q36311047 | Predictors of one-year mortality at hospital discharge after acute coronary syndromes: A new risk score from the EPICOR (long-tErm follow uP of antithrombotic management patterns In acute CORonary syndrome patients) study |
| Q37082952 | Predictors of outcome and the lack of effect of percutaneous coronary intervention across the risk strata in patients with persistent total occlusion after myocardial infarction: Results from the OAT (Occluded Artery Trial) study |
| Q46077941 | Predictors of the early outcome in elderly patients with ST elevation myocardial infarction treated with primary angioplasty: a single center experience |
| Q36341776 | Presentation, management and mortality after a first MI in people with and without asthma: A study using UK MINAP data |
| Q99241206 | Prevalence of Acute Coronary Syndrome and Various Risk Factors in Acute Stroke Patients |
| Q33764739 | Procedural and long-term outcome of primary percutaneous coronary intervention in octogenarians |
| Q41010381 | Prognostic Value of Circulating Inflammatory Cells in Patients with Stable and Acute Coronary Artery Disease |
| Q92869596 | Prognostic Value of the PARIS Thrombotic Risk Score for 2-Year Mortality After Percutaneous Coronary Intervention |
| Q37703777 | Prognostic score for acute coronary syndrome in a private terciary hospital. |
| Q42654441 | Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb. PARAGON-A and GUSTO IIb Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute Global Organization Network |
| Q42596817 | Prognostic value of isolated troponin elevation across the spectrum of chest pain syndromes |
| Q28193852 | Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non-ST-elevation acute coronary syndromes |
| Q33655036 | Prospective validation of the Dante Pazzanese risk score in non-ST-segment elevation acute coronary syndrome |
| Q43993838 | Quantitative analysis of the admission electrocardiogram identifies patients with unstable coronary artery disease who benefit the most from early invasive treatment |
| Q36935879 | Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial |
| Q57210706 | Regional variations in hospital management and post-discharge mortality in patients with non-ST-segment elevation acute coronary syndrome |
| Q40605441 | Relation of Low T3 to One-Year Mortality in Non-ST-Elevation Acute Coronary Syndrome Patients. |
| Q90483305 | Religious practices and long-term survival after hospital discharge for an acute coronary syndrome |
| Q36470182 | Remnant Lipoprotein Cholesterol and Mortality After Acute Myocardial Infarction: Further Evidence for a Hypercholesterolemia Paradox From the TRIUMPH Registry |
| Q37233293 | Resting heart rate and outcomes in patients with cardiovascular disease: where do we currently stand? |
| Q35152080 | Revised guidelines for the management of non-ST-segment elevation acute coronary syndromes |
| Q55414824 | Risk Score to Predict Need for Intensive Care in Initially Hemodynamically Stable Adults With Non-ST-Segment-Elevation Myocardial Infarction. |
| Q35691984 | Risk Stratification in Patients with Unstable Angina and Non-ST-elevation Myocardial Infarction |
| Q35871025 | Risk factors and clinical characteristics of in-hospital death in acute myocardial infarction with IABP support. |
| Q35135687 | Risk factors for rehospitalization for acute coronary syndromes and unplanned revascularization following acute myocardial infarction |
| Q37700207 | Risk prediction models for mortality in patients with cardiovascular disease: The BioBank Japan project |
| Q42246082 | Risk scores for patients with chest pain: evaluation in the emergency department |
| Q38009702 | Risk stratification and timing of revascularization: which patients benefit from early versus later revascularization? |
| Q26769732 | Risk stratification in non-ST elevation acute coronary syndromes: Risk scores, biomarkers and clinical judgment |
| Q73226867 | Risk stratification with cardiac troponin I in acute coronary syndromes |
| Q30438893 | Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention |
| Q43297579 | Serum Creatine Kinase-MB Isoenzyme Activity among Subjects with Uncomplicated Essential Hypertension: Any Sex Differences |
| Q37424804 | Sex differences in mortality following acute coronary syndromes |
| Q47758291 | Shared Decision-Making as the Future of Emergency Cardiology |
| Q37598027 | Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score |
| Q74587380 | Should we catheterize all patients with unstable angina? No--only the ones with coronary artery disease |
| Q37310382 | Simple integer risk score to determine prognosis of patients with hypertension and chronic stable coronary artery disease |
| Q34259243 | Systemic Inflammatory Response Syndrome Predicts Mortality in Acute Coronary Syndrome without Congestive Heart Failure |
| Q34604478 | Testing of low-risk patients presenting to the emergency department with chest pain: a scientific statement from the American Heart Association |
| Q36817207 | The NVVC working group guidelines for the management of patients with non-ST-elevation acute coronary syndromes |
| Q37599588 | The Seattle Post Myocardial Infarction Model (SPIM): prediction of mortality after acute myocardial infarction with left ventricular dysfunction |
| Q43012353 | The declining prevalence of ST elevation myocardial infarction in patients presenting with acute coronary syndromes |
| Q43832639 | The prognostic value of creatine kinase elevations extends across the whole spectrum of acute coronary syndromes |
| Q36196993 | The relationship between heart rate and mortality of patients with acute coronary syndromes in the coronary intervention era: Meta-analysis |
| Q34674157 | The role of pharmacotherapy and catheter-based intervention in the management of patients with non-ST-segment elevation acute coronary syndromes |
| Q28195431 | The thrombolysis in myocardial infarction risk score in unstable angina/non-ST-segment elevation myocardial infarction |
| Q37293684 | The use of risk scores for stratification of non-ST elevation acute coronary syndrome patients. |
| Q35878091 | Therapeutic strategies, immediate and mid-term outcomes in non-ST-segment elevation acute coronary syndromes with respect to age: a single-center registry of 488 consecutive patients |
| Q33359966 | Tirofiban and eptifibatide treatment of patients presenting with acute coronary syndrome with non-ST segment elevation |
| Q33414284 | Tolerability and feasibility of eptifibatide in acute coronary syndrome in patients at high risk for cardiovascular disease: A retrospective analysis |
| Q42606811 | Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial |
| Q40598936 | Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy |
| Q33752845 | Troponin-positive, MB-negative patients with non-ST-elevation myocardial infarction: An undertreated but high-risk patient group: Results from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network-Get W |
| Q30607483 | Understanding factors that influence the use of risk scoring instruments in the management of patients with unstable angina or non-ST-elevation myocardial infarction in the Netherlands: a qualitative study of health care practitioners' perceptions |
| Q44295155 | Unstable angina in the elderly |
| Q30000646 | Use of CHADS₂ and CHA₂DS₂-VASc scores to predict subsequent myocardial infarction, stroke, and death in patients with acute coronary syndrome: data from Taiwan acute coronary syndrome full spectrum registry |
| Q74587375 | Use of risk stratification to identify patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy |
| Q44193418 | Usefulness of the TIMI risk score in predicting both short- and long-term outcomes in the Veterans Affairs Non-Q-Wave Myocardial Infarction Strategies In-Hospital (VANQWISH) Trial |
| Q37283864 | Utilizing Chinese Admission Records for MACE Prediction of Acute Coronary Syndrome. |
| Q60913131 | Utilizing dynamic treatment information for MACE prediction of acute coronary syndrome |
| Q37387764 | Validation of the GRACE score for prognosis in Indian patients with acute coronary syndromes |
| Q44526662 | Value and role of lipid lowering therapy for cardiovascular prevention in the elderly |
| Q36738245 | Very Long-Term Prognostic Role of Admission BNP in Non-ST Segment Elevation Acute Coronary Syndrome |
| Q80577078 | [Prognostic value of Charlson comorbidity index at 30 days and 1 year after acute myocardial infarction] |
| Q80843600 | [Risk stratification of acute coronary syndromes] |
| Q58327576 | ¿Podemos mejorar la evolución de los pacientes con antecedentes de cirugía de bypass coronario ingresados por un síndrome coronario agudo? |
| Q26829973 | 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Associat |